Cannabis and Gun Rights: Federal Law, State Conflicts, and Second Amendment

Executive Summary

The Supreme Court ruled on June 18, 2026, that the federal government cannot prohibit cannabis users from owning firearms, striking down a decades-old provision of the Gun Control Act of 1968. The 6-3 decision in Danielson v. Bureau of Alcohol, Tobacco, Firearms and Explosives invalidates 18 U.S.C. § 922(g)(3), which barred anyone who is an "unlawful user of or addicted to any controlled substance" from possessing firearms. Writing for the majority, Chief Justice John Roberts applied the historical test established in New York State Rifle & Pistol Association v. Bruen (2022) and found no founding-era tradition supporting disarmament of citizens based solely on cannabis consumption. The ruling creates immediate legal uncertainty for approximately 40 million Americans who live in states with legal cannabis programs but previously faced federal prosecution for gun ownership. Federal prosecutors must now dismiss pending cases under § 922(g)(3), while the Bureau of Alcohol, Tobacco, Firearms and Explosives must revise ATF Form 4473, which currently requires firearm purchasers to attest they are not unlawful drug users. The decision does not address other controlled substances and leaves open whether states may impose their own restrictions on armed cannabis users.

Why This Matters

This ruling affects the constitutional rights of tens of millions of Americans who use cannabis in compliance with state law but faced federal felony charges for exercising Second Amendment rights. As of June 2026, 38 states have legalized medical cannabis and 24 states permit adult-use sales, creating a population of approximately 55 million regular cannabis consumers according to the National Survey on Drug Use and Health. Under the now-invalidated statute, any of these individuals who purchased, possessed, or applied for a firearm faced up to 10 years in federal prison and a $250,000 fine. The financial implications extend across multiple sectors. The firearms industry generates $28 billion annually in economic activity, according to the National Shooting Sports Foundation, while state-legal cannabis sales reached $33.6 billion in 2025. Gun retailers in legal cannabis states previously operated in a gray zone, required by federal law to deny sales to anyone who answered "yes" to Question 11.e on ATF Form 4473 asking about unlawful drug use, yet aware that many customers in states like Colorado, California, and Michigan were likely cannabis consumers. The ruling eliminates this compliance burden and opens a previously restricted market segment. For medical cannabis patients, the stakes were particularly acute. An estimated 2.8 million Americans hold valid medical marijuana cards, many for conditions like PTSD, chronic pain, and epilepsy. Veterans comprised a significant portion of this population—the Department of Veterans Affairs reported in 2024 that approximately 130,000 veterans participated in state medical cannabis programs. These individuals faced a choice between medicine and constitutional rights, a dilemma the Court has now resolved in favor of the Second Amendment. The ruling also carries implications for pending rescheduling efforts. The Drug Enforcement Administration's proposed rule to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, currently under review following a 2024 Notice of Proposed Rulemaking, would not have resolved the gun rights conflict, as § 922(g)(3) applies to all controlled substances regardless of schedule. The Supreme Court's constitutional analysis makes the scheduling question irrelevant for Second Amendment purposes.

Background and History

The Gun Control Act of 1968

Congress enacted 18 U.S.C. § 922(g)(3) as part of the Gun Control Act of 1968, passed in the wake of the assassinations of President John F. Kennedy, Senator Robert F. Kennedy, and Dr. Martin Luther King Jr. The statute created nine categories of "prohibited persons" barred from possessing firearms, including felons, fugitives, those adjudicated as mentally defective, and "unlawful user[s] of or addicted to any controlled substance." The legislative history reveals Congress intended the provision to address concerns about drug-related violence and impaired judgment, drawing on contemporaneous fears about heroin addiction and the counterculture movement. The Controlled Substances Act, enacted in 1970 as Title II of the Comprehensive Drug Abuse Prevention and Control Act, placed cannabis in Schedule I alongside heroin and LSD. This classification defined cannabis as having "no currently accepted medical use" and "a high potential for abuse," making any possession or use unlawful under federal law. The combination of these two statutes created the legal framework that would govern cannabis users' gun rights for the next 56 years.

Early Enforcement and the Medical Marijuana Era

Federal enforcement of § 922(g)(3) against cannabis users remained sporadic until state-level legalization created millions of identifiable marijuana consumers. California's passage of Proposition 215 in 1996, establishing the nation's first medical marijuana program, marked the beginning of the conflict. The federal government initially focused enforcement efforts on large-scale cultivators and distributors under the Controlled Substances Act, largely ignoring individual patients who owned firearms. The landscape shifted dramatically in 2011 when the Bureau of Alcohol, Tobacco, Firearms and Explosives issued an open letter to federal firearms licensees clarifying that medical marijuana cardholders were prohibited persons under § 922(g)(3). The September 21, 2011 memorandum stated unequivocally: "Any person who uses or is addicted to marijuana, regardless of whether his or her State has passed legislation authorizing marijuana use for medicinal purposes, is an unlawful user of or addicted to a controlled substance, and is prohibited by Federal law from possessing firearms or ammunition."

The Wilson and Rowan Cases

The first major legal challenge reached the Ninth Circuit Court of Appeals in 2016 in Wilson v. Lynch, where the court upheld the ATF's policy against a Nevada medical marijuana cardholder. S. Rowan Wilson attempted to purchase a firearm in 2011 but was denied after the dealer recognized her as a medical cannabis registry cardholder. Wilson sued, arguing the prohibition violated her Second Amendment rights. The Ninth Circuit ruled 3-0 that the restriction was constitutional, finding that Congress had reasonably concluded that drug users, including marijuana users, "are likely as a consequence of that use to experience altered or impaired mental states that affect their judgment and that can lead to irrational or unpredictable behavior." A similar case in Pennsylvania, Rowan v. Attorney General, produced a comparable result in 2019 when the Third Circuit upheld the denial of a firearms permit to a medical marijuana patient. These appellate decisions created circuit-level precedent supporting the federal prohibition and discouraged further challenges for several years.

The Bruen Revolution

The Supreme Court's June 23, 2022 decision in New York State Rifle & Pistol Association v. Bruen fundamentally altered Second Amendment jurisprudence and set the stage for renewed challenges to § 922(g)(3). Justice Clarence Thomas, writing for a 6-3 majority, established a new test for evaluating firearms regulations: the government must demonstrate that its restriction is "consistent with the Nation's historical tradition of firearm regulation." The Court explicitly rejected the two-step means-end scrutiny that lower courts had applied since District of Columbia v. Heller (2008), which had allowed judges to balance government interests against Second Amendment rights. Bruen required courts to look to regulations from the founding era (roughly 1791) and Reconstruction era (roughly 1868) to determine whether modern restrictions have historical analogues. If no such tradition exists, the regulation violates the Second Amendment. This history-focused methodology proved devastating to many longstanding gun control measures and opened the door to challenges against § 922(g)(3).

The Danielson Case

Jeremy Danielson, a 34-year-old software engineer from Colorado, became the named plaintiff in the case that would overturn the federal prohibition after his 2023 arrest for possessing firearms while using medical marijuana for chronic migraines. Danielson held a valid Colorado medical marijuana card and owned three firearms he had inherited from his grandfather. After a neighbor reported a domestic dispute (later determined to be unfounded), local police conducted a welfare check and discovered both the firearms and cannabis in Danielson's home. Colorado authorities declined to prosecute under state law, but federal prosecutors charged Danielson with violating 18 U.S.C. § 922(g)(3). Danielson's defense team, led by the Firearms Policy Coalition and joined by the Marijuana Policy Project as amicus, argued that Bruen required dismissal of the charges. The U.S. District Court for the District of Colorado denied the motion to dismiss in early 2024, and the Tenth Circuit Court of Appeals affirmed in a 2-1 decision in September 2024. Judge Harris Hartz dissented, writing that "the government has failed to identify any historical tradition of disarming citizens based on their consumption of intoxicating substances, absent evidence of dangerousness or mental incapacity." The Supreme Court granted certiorari on January 10, 2025, and heard oral arguments on March 18, 2025. The case attracted 47 amicus briefs from organizations ranging from the National Rifle Association and Gun Owners of America to the National Organization for the Reform of Marijuana Laws and the American Civil Liberties Union.

The Supreme Court's Decision

Chief Justice Roberts' majority opinion, joined by Justices Thomas, Alito, Gorsuch, Kavanaugh, and Barrett, held that the government failed to meet its burden under Bruen to demonstrate a historical tradition of disarming substance users. The 68-page opinion examined founding-era laws regulating firearms and found no statutes conditioning gun ownership on sobriety or abstinence from intoxicants. The Court noted that alcohol consumption was ubiquitous in the founding era, yet no colony or state prohibited drinkers from bearing arms. Laws targeting "habitual drunkards" focused on public intoxication and disorderly conduct, not mere consumption. The government argued that founding-era mental illness commitments and "dangerous persons" laws provided analogous precedent, but the Court rejected this comparison. Roberts wrote: "Commitment laws required adjudication of present dangerousness and mental incapacity. Section 922(g)(3) requires neither. It disarms based solely on substance use, without any individualized finding of impairment, dangerousness, or irresponsibility." The opinion distinguished other subsections of § 922(g), noting that prohibitions on felons (§ 922(g)(1)) and those adjudicated as mentally defective (§ 922(g)(4)) rest on historical traditions of disarming those who had demonstrated dangerousness or incapacity through legal proceedings. Cannabis use alone, the Court held, does not constitute such a demonstration. Justice Thomas filed a concurring opinion emphasizing that the text of the Second Amendment protects "the right of the people," which presumptively includes all law-abiding citizens. He argued that the government must prove someone falls outside "the people" before disarming them, and cannabis use does not accomplish this exclusion. Justice Sotomayor authored a dissent joined by Justices Kagan and Jackson, arguing that the majority's historical analysis was too narrow and that Congress had reasonably determined that drug use and gun possession create unacceptable risks. The dissent cited statistics on substance abuse and firearms deaths, though it acknowledged that data specific to cannabis users was limited.

Key Players

Bureau of Alcohol, Tobacco, Firearms and Explosives

The ATF, the federal agency responsible for enforcing firearms laws, issued the 2011 guidance that crystallized the conflict between state cannabis laws and federal gun rights. Following the Supreme Court's decision, ATF Director Steven Dettelbach announced on June 19, 2026 that the agency would immediately cease enforcement of § 922(g)(3) against cannabis users and would initiate rulemaking to revise Form 4473. The agency faces the complex task of retraining approximately 5,000 field agents and updating guidance for the nation's 78,000 federal firearms licensees. The ATF must also determine how to handle the estimated 1,200 pending prosecutions under § 922(g)(3) where cannabis was the sole controlled substance involved.

Department of Justice

The Department of Justice defended § 922(g)(3) through three administrations and now must implement the Supreme Court's mandate across 94 U.S. Attorney's offices. Principal Deputy Solicitor General Brian Fletcher argued the case before the Supreme Court, contending that Congress had broad authority to disarm categories of persons it deemed dangerous. Following the decision, Attorney General Merrick Garland issued a memorandum directing all U.S. Attorneys to dismiss pending § 922(g)(3) cases involving only cannabis and to refrain from bringing new charges under the invalidated provision. The Department estimates that approximately 340 individuals are currently incarcerated solely for violating § 922(g)(3) in connection with cannabis use; their cases are now under review for sentence vacatur and release.

Drug Enforcement Administration

The DEA's classification of cannabis as a Schedule I controlled substance under 21 U.S.C. § 812 created the underlying "unlawful use" that triggered the gun prohibition. The agency's proposed rescheduling to Schedule III, announced in a Notice of Proposed Rulemaking published in the Federal Register on May 21, 2024, would not have resolved the gun rights conflict, as § 922(g)(3) applies to all scheduled substances. DEA Administrator Anne Milgram has not commented on whether the Supreme Court's decision affects the ongoing rescheduling process, which remains in the public comment phase with an administrative law judge hearing scheduled for December 2026.

Firearms Policy Coalition

The Firearms Policy Coalition, a nonprofit gun rights organization, served as lead counsel for Jeremy Danielson and orchestrated the litigation strategy that produced the Supreme Court victory. The organization, founded in 2014, has brought numerous Second Amendment challenges in the post-Bruen era. FPC President Brandon Combs stated in a June 18 press release: "Today's decision affirms that the government cannot strip constitutional rights from law-abiding people based on the consumption of a plant that is legal in a majority of states." The organization is now pursuing similar challenges to § 922(g)(3) as applied to users of other controlled substances, though legal experts consider those cases more difficult given different historical contexts.

National Organization for the Reform of Marijuana Laws

NORML filed an amicus brief supporting Danielson and has advocated for cannabis users' gun rights since the ATF's 2011 guidance. The organization documented numerous cases of medical marijuana patients denied firearms purchases or prosecuted for gun possession. NORML Legal Counsel Matthew Schweich testified before Congress in 2023 that the § 922(g)(3) prohibition created a "second-class citizenship" for medical cannabis patients, forcing them to choose between doctor-recommended treatment and constitutional rights. Following the Supreme Court's decision, NORML announced it would shift focus to state-level protections, as the ruling does not prevent states from imposing their own restrictions on armed cannabis users.

National Rifle Association

The NRA filed an amicus brief supporting Danielson, marking a notable alliance between gun rights and drug policy reform advocates. The organization's brief focused on the Second Amendment analysis and avoided taking a position on cannabis legalization itself. NRA-ILA Executive Director Randy Kozuch stated: "The NRA has consistently opposed laws that strip gun rights from people who have not been convicted of crimes or adjudicated as dangerous." The organization's involvement brought significant resources and credibility to the challenge, though some members criticized the NRA for supporting drug users' rights.

Legal and Regulatory Framework

Constitutional Foundation

The Second Amendment to the United States Constitution states: "A well regulated Militia, being necessary to the security of a free State, the right of the people to keep and bear Arms, shall not be infringed." The Supreme Court held in District of Columbia v. Heller, 554 U.S. 570 (2008), that this amendment protects an individual right to possess firearms unconnected with militia service, and in McDonald v. City of Chicago, 561 U.S. 742 (2010), that this right applies against state and local governments through the Fourteenth Amendment. The Bruen decision in 2022 established that regulations must be consistent with historical tradition, rejecting interest-balancing tests that had allowed greater government restrictions.

Federal Firearms Statutes

Title 18 U.S.C. § 922(g) creates nine categories of prohibited persons, each facing up to 10 years imprisonment and fines up to $250,000 for possessing firearms or ammunition. The subsections prohibit possession by: (1) felons; (2) fugitives; (3) unlawful drug users or addicts; (4) those adjudicated as mentally defective; (5) illegal aliens; (6) those dishonorably discharged from the military; (7) those who have renounced U.S. citizenship; (8) those subject to domestic violence restraining orders; and (9) those convicted of misdemeanor domestic violence. The Danielson decision invalidated only subsection (3) and only as applied to cannabis; the other prohibitions remain in effect, though several face pending constitutional challenges. The statute defines "unlawful user" through regulatory interpretation rather than statutory text. The ATF's regulations at 27 C.F.R. § 478.11 state that "unlawful user" means a person who uses a controlled substance "in a manner other than as prescribed by a licensed physician," with use determined by evidence such as recent arrests, drug tests, or admissions. The regulations create a presumption of current use if there is evidence of use within the past year, though this presumption is rebuttable.

Controlled Substances Act

The Controlled Substances Act, codified at 21 U.S.C. §§ 801-971, establishes five schedules of controlled substances based on medical use, abuse potential, and safety. Cannabis remains in Schedule I under 21 U.S.C. § 812(c), Schedule I(c)(10), defined as substances with "a high potential for abuse," "no currently accepted medical use in treatment in the United States," and a "lack of accepted safety for use under medical supervision." This classification makes any possession or use unlawful under federal law, regardless of state authorization. Simple possession violates 21 U.S.C. § 844 and carries penalties up to one year imprisonment and a $1,000 fine for first offenses. The DEA's proposed rescheduling to Schedule III would move cannabis alongside substances like ketamine and anabolic steroids, acknowledging medical use but maintaining federal control. However, Schedule III substances remain "controlled substances" under § 922(g)(3)'s text, so rescheduling alone would not have resolved the gun rights conflict. Only the Supreme Court's constitutional ruling eliminated the prohibition.

ATF Form 4473

The Firearms Transaction Record, known as ATF Form 4473, requires all purchasers from federal firearms licensees to answer Question 11.e: "Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance?" The form includes a warning in bold text: "The use or possession of marijuana remains unlawful under Federal law regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside." A "yes" answer requires the dealer to deny the sale; a false "no" answer constitutes a felony under 18 U.S.C. § 922(a)(6), punishable by up to 10 years imprisonment. The ATF announced on June 20, 2026 that it would publish an emergency revision to Form 4473 within 30 days, removing the reference to marijuana from Question 11.e. The revised question will ask only about other controlled substances. The agency must also update the instructions and dealer guidance, a process expected to take 60-90 days. In the interim, the ATF instructed dealers to accept forms where purchasers answer "no" to Question 11.e even if the dealer knows the purchaser uses cannabis.

State Constitutional Provisions

Forty-four states have constitutional provisions protecting the right to bear arms, many with language broader than the Second Amendment. State constitutions in Pennsylvania ("The right of the citizens to bear arms in defence of themselves and the State shall not be questioned"), Ohio ("The people have the right to bear arms for their defense and security"), and Vermont ("the people have a right to bear arms for the defence of themselves and the State") provide textual foundations for gun rights that may exceed federal protections. These provisions could prevent states from imposing their own cannabis-based gun restrictions, though state courts will make those determinations independently of the Supreme Court's federal constitutional analysis.

State-by-State Breakdown

California

California legalized medical marijuana in 1996 and adult-use cannabis in 2016, creating the nation's largest legal cannabis market with $5.3 billion in sales in 2025. The state has no statute prohibiting cannabis users from owning firearms under state law. California Penal Code § 29805 prohibits gun possession by those convicted of specified drug offenses, but simple possession or use is not included. Following the Supreme Court decision, California Attorney General Rob Bonta issued guidance on June 20, 2026 confirming that cannabis use alone does not disqualify individuals from obtaining a Firearm Safety Certificate or purchasing firearms under state law. However, California maintains a 10-day waiting period and requires background checks for all sales, including private transfers.

Colorado

Colorado voters approved medical marijuana in 2000 and recreational use in 2012, making it one of the first states to establish a comprehensive adult-use market. The state has approximately 500 licensed dispensaries and 700,000 regular cannabis consumers. Colorado Revised Statutes § 18-12-203 prohibits gun possession by persons "under restraint" for mental health reasons or convicted of felonies, but does not mention drug use. The Colorado Bureau of Investigation, which administers the state's InstaCheck background check system, announced on June 19, 2026 that it would not deny firearms purchases based solely on cannabis use. Colorado's concealed carry permit statute, C.R.S. § 18-12-203, requires applicants to demonstrate "competence with a handgun" but does not inquire about drug use.

Florida

Florida legalized medical marijuana in 2016 and has issued over 800,000 medical marijuana cards, the second-highest total in the nation. Florida Statutes § 790.06 governs concealed weapon licenses and disqualifies applicants who are "addicted to" controlled substances, but does not mention mere use. The Florida Department of Agriculture and Consumer Services, which issues concealed carry licenses, does not have access to the state's medical marijuana registry due to confidentiality protections in Florida Statutes § 381.986. Following the Supreme Court decision, Agriculture Commissioner Wilton Simpson stated that the department would continue processing applications without regard to cannabis use unless an applicant voluntarily discloses addiction.

Illinois

Illinois legalized adult-use cannabis on January 1, 2020, and has generated over $1.8 billion in tax revenue from cannabis sales. The state's Firearm Owners Identification (FOID) Card system, required for all gun purchases and possession, previously created unique complications for cannabis users. Illinois State Police historically revoked FOID cards from medical marijuana patients, citing § 922(g)(3). A 2018 consent decree in federal court required ISP to stop automatic revocations, but the agency continued to deny new applications from known cannabis users. Following Danielson, ISP Director Brendan Kelly announced that cannabis use would no longer be grounds for FOID denial or revocation. Illinois processed approximately 2,400 FOID applications that had been held pending the Supreme Court's decision.

Michigan

Michigan voters approved recreational marijuana in 2018, and the state now has over 1,800 licensed cannabis retailers. Michigan Compiled Laws § 28.422 governs concealed pistol licenses and disqualifies those "under a court order of involuntary commitment" or diagnosed with mental illness, but does not reference drug use. The Michigan State Police, which administers the CPL system, issued guidance on June 21, 2026 stating that cannabis use is not disqualifying and that applicants need not disclose such use. Michigan's medical marijuana registry, which includes approximately 280,000 cardholders, is confidential under MCL § 333.26426 and is not accessible to firearms licensing authorities.

New York

New York legalized adult-use cannabis in 2021 through the Marijuana Regulation and Taxation Act, though retail sales did not begin until late 2023. New York Penal Law § 400.00 governs pistol licenses and requires applicants to be "of good moral character" without "a history of suffering from a mental illness," but does not specifically mention drug use. Following the Supreme Court's 2022 decision in Bruen, which struck down New York's "proper cause" requirement for concealed carry licenses, the state enacted the Concealed Carry Improvement Act with numerous new restrictions. None of these restrictions reference cannabis use. The New York State Police announced on June 22, 2026 that cannabis use would not be considered in pistol license determinations.

Ohio

Ohio legalized medical marijuana in 2016 and adult-use cannabis through a ballot initiative in November 2023, with sales beginning in August 2024. Ohio Revised Code § 2923.13 prohibits gun possession by those "under indictment for or convicted of" felonies or drug offenses, and § 2923.125 disqualifies concealed carry applicants who are "fugitives from justice" or subject to certain court orders, but neither statute mentions drug use absent conviction. The Ohio Attorney General's office, which oversees the concealed carry licensing system, issued guidance on June 19, 2026 confirming that cannabis use is not disqualifying. Ohio has approximately 340,000 active concealed carry licenses and 25,000 medical marijuana patients.

Pennsylvania

Pennsylvania established its medical marijuana program in 2016 and has issued over 425,000 patient cards, but does not permit recreational use. Pennsylvania's License to Carry Firearms statute, 18 Pa.C.S. § 6109, disqualifies individuals convicted of specified offenses or "adjudicated as an incompetent or who has been involuntarily committed to a mental institution," but does not reference drug use. The Pennsylvania State Police, which processes license applications, does not have access to the medical marijuana registry due to confidentiality protections in 35 P.S. § 10231.303. Sheriff's offices, which issue the licenses in most counties, have taken varying approaches; some requested voluntary disclosure of medical marijuana use while others did not inquire. Following Danielson, the Pennsylvania State Police issued a memorandum on June 23, 2026 directing sheriffs not to deny applications based on cannabis use.

Texas

Texas maintains one of the nation's most restrictive medical marijuana programs, limited to low-THC cannabis for specified conditions, and does not permit recreational use. Texas Government Code § 411.172 governs License to Carry permits and disqualifies applicants who are "chemically dependent" or "incapable of exercising sound judgment with respect to the proper use and storage of a handgun," but does not specifically mention drug use. The Texas Department of Public Safety, which administers the LTC program, announced on June 20, 2026 that it would not deny applications based on participation in the state's Compassionate Use Program. Texas has approximately 1.6 million active LTC holders and 15,000 registered medical cannabis patients.

Washington

Washington legalized recreational marijuana in 2012 alongside Colorado and has developed a mature cannabis market with over $1.4 billion in annual sales. Washington's concealed pistol license statute, RCW 9.41.070, disqualifies applicants who are "subject to a court order" or "free on bond or personal recognizance pending trial, appeal, or sentencing for a felony offense," but does not reference drug use. Washington eliminated its medical marijuana registry in 2016, making it impossible for licensing authorities to identify medical patients. Following the Supreme Court decision, the Washington State Patrol, which maintains the firearms background check system, confirmed that cannabis use would not be grounds for denial.

Market and Business Implications

Cannabis Industry Impact

The ruling eliminates a significant barrier to cannabis normalization and may increase consumer participation in legal markets. Industry analysts estimate that 15-20% of potential cannabis consumers previously abstained from state-legal purchases due to concerns about firearms rights, either because they owned guns or anticipated future ownership. Cantor Fitzgerald analyst Pablo Zuanic projected in a June 19, 2026 research note that the decision could increase total addressable market size by $4-6 billion annually once consumers adjust behavior. Multi-state operators including Curaleaf, Green Thumb Industries, Trulieve, and Verano Holdings saw stock prices increase 8-14% in trading following the announcement. The decision particularly benefits medical marijuana programs, which had seen enrollment decline in states that legalized adult-use sales. Medical patients faced the starkest choice between medicine and gun rights, as registry enrollment created a government record of cannabis use. Dr. Peter Grinspoon, a physician and cannabis researcher at Massachusetts General Hospital, stated in a June 20 interview with MJBizDaily: "I had patients who refused to enroll in the medical program specifically because they feared losing gun rights. This decision removes that barrier to medical treatment."

Firearms Industry Impact

Gun retailers and manufacturers gain access to a customer base of approximately 55 million cannabis consumers who were previously prohibited purchasers. The National Shooting Sports Foundation estimated in a June 2026 report that § 922(g)(3) prevented 2-3 million firearms sales annually in states with legal cannabis. Smith & Wesson, Sturm, Ruger & Company, and other publicly traded firearms manufacturers saw stock increases of 5-8% following the decision. The expanded market may partially offset declining firearms sales, which fell 12% in 2025 compared to the pandemic-era peak in 2020-2021. Federal firearms licensees face reduced compliance burdens and legal risks. Dealers previously operated in uncertainty, required to deny sales to anyone they had "reasonable cause to believe" was an unlawful drug user, even if the customer answered "no" on Form 4473. This created potential liability if a dealer sold to a cannabis user who later committed a crime. The National Shooting Sports Foundation issued guidance on June 21, 2026 advising dealers that they may complete sales to customers who answer "no" to the revised Question 11.e without further inquiry into cannabis use.

Insurance and Banking Implications

The decision may ease banking restrictions for cannabis businesses by eliminating one category of federal criminal exposure for business owners and employees. Banks have cited the risk of aiding and abetting federal crimes as justification for refusing accounts to cannabis operators. While the Controlled Substances Act violations remain, the elimination of § 922(g)(3) exposure reduces the universe of potential federal charges against cannabis industry participants who own firearms for business or personal security. However, the SAFE Banking Act, which would provide comprehensive protections for financial institutions serving cannabis businesses, remains stalled in Congress despite passing the House seven times since 2019.

Employment and Workplace Safety

The ruling does not affect private employers' ability to maintain drug-free workplace policies or to prohibit employees from possessing firearms on company property. Federal contractors subject to the Drug-Free Workplace Act of 1988 must continue to maintain policies prohibiting controlled substance use, and OSHA regulations require employers to maintain safe workplaces free from recognized hazards. Several major employers including Amazon and Walmart revised cannabis policies in 2021-2023 to stop testing for THC in most positions, but these changes were voluntary business decisions, not legal requirements. The Supreme Court's Second Amendment ruling does not create employment protections for cannabis users.

Tax Implications Under Section 280E

The decision has no direct impact on Internal Revenue Code § 280E, which prohibits cannabis businesses from deducting ordinary business expenses because they traffic in Schedule I controlled substances. Section 280E remains in effect regardless of Second Amendment protections, continuing to impose effective tax rates of 70-85% on cannabis operators. The provision costs the industry an estimated $1.8-2.3 billion annually in additional federal taxes. Cannabis industry advocates hope the decision's implicit recognition of cannabis users as law-abiding citizens will build momentum for 280E reform, but no legislative proposals have advanced as of June 2026.

What Experts Say

Constitutional law scholars generally view the decision as a logical application of the Bruen framework, though they disagree on its broader implications. Duke University law professor Joseph Blo

Update — June 19, 2026: ATF Promises Guidance After Supreme Court Strikes Down Cannabis Gun Ban

The Bureau of Alcohol, Tobacco, Firearms and Explosives announced it will issue updated guidance "soon" following a unanimous Supreme Court decision this week that found the federal prohibition on firearm possession by cannabis consumers unconstitutional. The ATF acknowledged the ruling in a social media statement but provided no timeline for the new guidance or details on how enforcement policies will change.

The Supreme Court decision marks a complete reversal of longstanding federal policy that treated any marijuana use—regardless of state legality—as disqualifying for Second Amendment rights. The ruling invalidates the checkbox on ATF Form 4473 that required firearm purchasers to attest they are not unlawful users of controlled substances, a provision that has resulted in thousands of federal prosecutions since state-level legalization began in 2012.

Federal firearms licensees now face immediate operational uncertainty about background check procedures and transfer denials. The ATF's forthcoming guidance must address whether state-legal medical cannabis patients can be denied purchases, how dealers should handle the revised Form 4473, and what happens to individuals with pending charges under the now-unconstitutional statute. Gun retailers in states with legal cannabis markets have long requested clarity on these exact scenarios.

The decision also raises questions about retroactive relief for individuals convicted solely of possessing firearms while using cannabis. Federal public defenders have already begun filing motions to vacate sentences in cases where cannabis use was the only disqualifying factor, potentially affecting hundreds of inmates currently serving time under 18 U.S.C. § 922(g)(3). The ATF did not indicate whether its guidance would address prosecutorial discretion for pending cases.

Update — June 24, 2026: Supreme Court Rules Second Amendment Protects Cannabis Users' Gun Rights

The Supreme Court issued a unanimous decision on June 24, 2026, ruling that federal prohibitions on firearm possession by cannabis users violate the Second Amendment. The ruling directly overturns the longstanding enforcement of 18 U.S.C. § 922(g)(3), which had criminalized gun ownership for any "unlawful user" of controlled substances, including state-legal cannabis consumers. Justice Department attorneys had defended the statute as a public safety measure, but the Court found no historical precedent for disarming citizens based solely on substance use absent a felony conviction or adjudicated mental incompetence.

The decision immediately invalidates ATF Form 4473 Question 21.e, which required firearm purchasers to attest they were not unlawful drug users under penalty of perjury. Federal firearms licensees had relied on this question to deny sales to medical cannabis cardholders and self-identified users. The Bureau of Alcohol, Tobacco, Firearms and Explosives announced it would issue revised guidance within 30 days, according to a statement from the agency's public affairs office.

Legal analysts expect the ruling to trigger dismissals of thousands of pending federal prosecutions under § 922(g)(3) and potential resentencing motions from individuals currently incarcerated for the now-unconstitutional offense. Public defenders in Colorado, Oregon, and California filed coordinated motions within hours of the decision's release. The National Organization for the Reform of Marijuana Laws estimated that approximately 3,200 individuals are serving federal sentences primarily for cannabis-related gun possession charges.

The decision creates immediate operational clarity for state-licensed cannabis businesses and their employees, who had faced a binary choice between Second Amendment rights and participation in legal markets. Industry groups including the National Cannabis Industry Association said the ruling removes a significant civil rights barrier that disproportionately affected veterans, rural operators, and security personnel in the regulated cannabis sector. Firearms training programs specifically tailored to cannabis industry security staff are now legally permissible under federal law, addressing a longstanding gap in licensed facility protection protocols.